W975 Pill: white, oval, 19mm
The pill with imprint W975 (White, Oval, 19mm) has been identified as Divalproex Sodium Delayed-Release 500 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.
Images for W975
Divalproex Sodium Delayed-Release
- Imprint
- W975
- Strength
- 500 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wockhardt USA
- National Drug Code (NDC)
- 64679-0975 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
dimethicone,
hypromelloses,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol,
polysorbate 80,
povidone,
silicon dioxide,
sodium bicarbonate,
sodium lauryl sulfate,
corn starch,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
See also:
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (514)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.